A new fluorescence-based method for characterizing in vitro aerosol exposure systems

Toxicology in Vitro

Volumn 38, Issue , 2017, Pages 150-158

  Steiner, Sandro ^a   Majeed, Shoaib ^a   Kratzer, Gilles ^a   Hoeng, Julia ^a   Frentzel, Stefan ^a  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

Author keywords

Aerosol dosimetry; Aerosol exposure system characterization; In vitro aerosol exposure; Vitrocell

Indexed keywords

AEROSOL; DISEASE SIMULATION; DOSIMETRY; EXPERIMENTAL MODEL; FEASIBILITY STUDY; FLUORESCENCE; FLUOROMETRY; IN VITRO STUDY; PARTICLE SIZE; REPRODUCIBILITY; ADMINISTRATION AND DOSAGE; CHEMISTRY; PROCEDURES; TOXICITY TESTING;

AEROSOL; FLUORESCEIN; FLUORESCENT DYE; GLYCEROL;

AEROSOLS; FLUORESCEIN; FLUORESCENCE; FLUORESCENT DYES; FLUOROMETRY; GLYCEROL; PARTICLE SIZE; TOXICITY TESTS;

EID: 84992118296     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2016.09.018     Document Type: Article

References (52)

1. Adamson, J., et al. Real-time assessment of cigarette smoke particle deposition in vitro. Chemistry Central Journal, 6(1), 2012, 98.
2. Adamson, J., et al. An inter-machine comparison of tobacco smoke particle deposition in vitro from six independent smoke exposure systems. Toxicol. in Vitro 28:7 (2014), 1320–1328.
3. Alonso, M., et al. Aerosol particle size growth by simultaneous coagulation and condensation with diffusion losses in laminar flow tubes. J. Aerosol Sci. 30:9 (1999), 1191–1199.
4. Asimakopoulou, A., et al. Characterization of a multiculture in-vitro cell exposure chamber for assessing the biological impact of diesel engine exhaust. in InternationalConferenceonSafeProductionandUseofNanomaterials. J. Phys., 2011.
5. Aufderheide, M., et al. The CULTEX RFS: a comprehensive technical approach for the in vitro exposure of airway epithelial cells to the particulate matter at the air-liquid interface. Biomed. Res. Int., 2013, 2013.
6. Belka, M., et al. Comparison of methods for evaluation of aerosol deposition in the model of human lungs. in EPJ Web of Conferences. 2014, EDP Sciences.
7. BéruBé, K., et al. Human primary bronchial lung cell constructs: the new respiratory models. Toxicology 278:3 (2010), 311–318.
8. Bowes, S.M. III, Swift, D.L., Deposition of inhaled particles in the oral airway during oronasal breathing. Aerosol Sci. Technol. 11:2 (1989), 157–167.
9. Cervellati, F., et al. Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. Toxicol. in Vitro 28:5 (2014), 999–1005.
10. Chang, P.-T., Peters, L.K., Ueno, Y., Particle size distribution of mainstream cigarette smoke undergoing dilution. Aerosol Sci. Technol. 4:2 (1985), 191–207.
11. Farsalinos, K.E., Polosa, R., Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Therapeutic advances in drug safety 5:2 (2014), 67–86.
12. Feng, Y., Kleinstreuer, C., Rostami, A., Evaporation and condensation of multicomponent electronic cigarette droplets and conventional cigarette smoke particles in an idealized G3–G6 triple bifurcating unit. J. Aerosol Sci. 80 (2015), 58–74.
13. Fröhlich, E., et al. Comparison of two in vitro systems to assess cellular effects of nanoparticles-containing aerosols. Toxicol. in Vitro 27:1 (2013), 409–417.
14. Fujitani, Y., et al. Particle deposition efficiency at air–liquid interface of a cell exposure chamber. J. Aerosol Sci. 81 (2015), 90–99.
15. Goniewicz, M.L., et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob. Control. 23:2 (2014), 133–139.
16. Grass, R.N., et al. Exposure of aerosols and nanoparticle dispersions to in vitro cell cultures: a review on the dose relevance of size, mass, surface and concentration. J. Aerosol Sci. 41:12 (2010), 1123–1142.
17. Guha, A., Transport and Deposition of Particles in Turbulent and Laminar Flow. 2008.
18. Haghi, M., et al. Towards the bioequivalence of pressurised metered dose inhalers 2. Aerodynamically equivalent particles (with and without glycerol) exhibit different biopharmaceutical profiles in vitro. Eur. J. Pharm. Biopharm. 86:1 (2014), 38–45.
19. Hajek, P., et al. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction 109:11 (2014), 1801–1810.
20. Health-Canada, Determination of Tar, Water, Nicotine and Carbon Monoxide in Mainstream Tobacco Smoke. Health Canada Test Method T-115, 1999.
21. Heyder, J., Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc. Am. Thorac. Soc. 1:4 (2004), 315–320.
22. Hirsch, V., et al. Surface charge of polymer coated SPIONs influences the serum protein adsorption, colloidal stability and subsequent cell interaction in vitro. Nanomedicine 5:9 (2013), 3723–3732.
23. Ishikawa, S., Nagata, Y., Suzuki, T., Analysis of Cigarette Smoke Deposition Within an In Vitro Exposure System for Simulating Exposure in the Human Respiratory Tract. Beiträge zur Tabakforschung/Contributions to Tobacco Research 27:1 (2016), 20–29.
24. Kaur, N., et al. Evaluation of precision and accuracy of the Borgwaldt RM20S® smoking machine designed for in vitro exposure. Inhal. Toxicol. 22:14 (2010), 1174–1183.
25. Kesavan, J., Doherty, R.W., Use of Fluorescein in Aerosol Studies., 2000 DTIC Document.
26. Kim, J.S., et al. Validation of an in vitro exposure system for toxicity assessment of air-delivered nanomaterials. Toxicol. in Vitro 27:1 (2013), 164–173.
27. Koehler, K.A., et al. Solid versus liquid particle sampling efficiency of three personal aerosol samplers when facing the wind. Ann. Occup. Hyg. 56:2 (2012), 194–206.
28. Lízal, F., et al. Experimental study of aerosol deposition in a realistic lung model. Transactions of the VŠB – Technical University of Ostrava. Mechanical Series, 56(3), 2010, 6.
29. Lizal, F., et al. Aerosol transport in a model of human lungs. In EPJ Web of Conferences. 2012, EDP Sciences.
30. Majeed, S., et al. Characterization of the Vitrocell® 24/48 in vitro aerosol exposure system using mainstream cigarette smoke. Chemistry Central Journal, 8(1), 2014, 62.
31. Marple, V.A., Rubow, K.L., Behm, S.M., A microorifice uniform deposit impactor (MOUDI): description, calibration, and use. Aerosol Sci. Technol. 14:4 (1991), 434–446.
32. Mertes, P., et al. A compact and portable deposition chamber to study nanoparticles in air-exposed tissue. Journal of aerosol medicine and pulmonary drug delivery 26:4 (2013), 228–235.
33. Mullins, B.J., Agranovski, I.E., Braddock, R.D., Particle bounce during filtration of particles on wet and dry filters. Aerosp. Sci. Technol. 37:7 (2003), 587–600.
34. Neilson, L., et al. Development of an in vitro cytotoxicity model for aerosol exposure using 3D reconstructed human airway tissue; application for assessment of e-cigarette aerosol. Toxicol. in Vitro 29:7 (2015), 1952–1962.
35. Panas, A., et al. Silica nanoparticles are less toxic to human lung cells when deposited at the air–liquid interface compared to conventional submerged exposure. Beilstein journal of nanotechnology 5:1 (2014), 1590–1602.
36. Patton, J.S., Byron, P.R., Inhaling medicines: delivering drugs to the body through the lungs. Nat. Rev. Drug Discov. 6:1 (2007), 67–74.
37. Paur, H.R., et al. In vitro exposure systems and bioassays for the assessment of toxicity of nanoparticles to the human lung. Journal Fur Verbraucherschutz Und Lebensmittelsicherheit-Journal of Consumer Protection and Food Safety 3:3 (2008), 319–329.
38. Paur, H.R., et al. In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lung-a dialog between aerosol science and biology. J. Aerosol Sci. 42:10 (2011), 668–692.
39. Pepper, J.K., Eissenberg, T., Waterpipes and electronic cigarettes: increasing prevalence and expanding science. Chem. Res. Toxicol. 27:8 (2014), 1336–1343.
40. Pisinger, C., Døssing, M., A systematic review of health effects of electronic cigarettes. Prev. Med. 69 (2014), 248–260.
41. Riker, C.A., et al. E-cigarettes: promise or peril?. Nurs. Clin. N. Am. 47:1 (2012), 159–171.
42. Sahu, S., et al. Particle size distribution of mainstream and exhaled cigarette smoke and predictive deposition in human respiratory tract. Aerosol Air Qual. Res. 13 (2013), 324–332.
43. Scheffler, S., et al. Cytotoxic evaluation of e-liquid aerosol using different lung-derived cell models. Int. J. Environ. Res. Public Health 12:10 (2015), 12466–12474.
44. Schripp, T., et al. Does e-cigarette consumption cause passive vaping?. Indoor Air 23:1 (2013), 25–31.
45. Scian, M.J., et al. Characterization of a whole smoke in vitro exposure system (Burghart mimic smoker-01). Inhal. Toxicol. 21:3 (2009), 234–243.
46. Shen, Y., et al. Transcriptome sequencing reveals e-cigarette vapor and mainstream-smoke from tobacco cigarettes activate different gene expression profiles in human bronchial epithelial cells. Sci. Report., 6, 2016.
47. Thorne, D., Adamson, J., A review of in vitro cigarette smoke exposure systems. Exp. Toxicol. Pathol. 65:7 (2013), 1183–1193.
48. Tippe, A., Heinzmann, U., Roth, C., Deposition of fine and ultrafine aerosol particles during exposure at the air/cell interface. J. Aerosol Sci. 33:2 (2002), 207–218.
49. Watts, A.B., McConville, J.T., Williams, R.O. III, Current therapies and technological advances in aqueous aerosol drug delivery. Drug Dev. Ind. Pharm. 34:9 (2008), 913–922.
50. Weidner, C., et al. Mine Water – Managing the Challenges. parameters affecting na-fluorescein (uranine) detection in mine water tracer tests. 2011 Aachen, Germany.
51. Wiegand, H., Meyer, J., Kasper, G., An electrical conductivity based method of determining the particle deposition rate in air–liquid interface devices. Toxicol. in Vitro 29:5 (2015), 1100–1106.
52. Yannuzzi, L.A., et al. Fluorescein angiography complication survey. Ophthalmology 93:5 (1986), 611–617.